Vorsitz: J. Backs (Heidelberg), S. Baldus (Köln)
| (V151) | Endothelial microparticles reduce neointima formation and vascular smooth muscle cell proliferation in a microRNA-126-dependent mechanism | |
| F. Jansen, T. Stumpf, A. Flender, T. Schmitz, G. Nickenig, N. Werner (Bonn) | ||
| Diskussion | ||
| (V152) | MicroRNA-146a Augments Vascular Smooth Muscle Cell Proliferation and Neointima Formation | |
| L. Korte, R. Teske, K. Donde, J. Dutzmann, J. M. Daniel, J. Bauersachs, D. G. Sedding (Hannover, Gießen) | ||
| Diskussion | ||
| (V153) | Local microRNA modulation using a novel anti-miR-21-eluting stent effectively prevents in-stent restenosis | |
| D. Wang, T. Deuse, M. Stubbendorff, S. Eken, H. Jin, C.-H. Heeger, B. Behnisch, H. Reichenspurner, P. S. Tsao, S. Schrepfer, L. Maegdefessel (Hamburg, Hechingen; Stockholm, SE; Stanford, US) | ||
| Diskussion | ||
| (V154) | Hypoxia regulates endothelial circular RNAs independent on the expression of host genes. | |
| A. Heumüller, J.-N. Boeckel, N. Jae, W. Chen, R. A. Boon, S. Fichtlscherer, A. M. Zeiher, D. John, S. Uchida, S. Dimmeler (Frankfurt am Main, Berlin) | ||
| Diskussion | ||
| (V155) | The lncRNA SLFNL1-AS1 regulates fibrous cap stability in vulnerable atherosclerotic lesions | |
| H. Jin, S. Eken, E. Chernugobova, N. Leeper, P. Eriksson, G. Hansson, U. Hedin, L. Maegdefessel (Stockholm, SE; Stanford, US) | ||
| Diskussion | ||
| (V156) | Asymmetric Dimethylarginin Induces Endothelial Dysfunction via modulation of miR-126 | |
| F. Martino, C. Bang, F. Schöttmer, J. T. Kielstein, J. Lorenzen, T. Thum (Hannover) | ||
| Diskussion |